Bingyang Chu

3.7k total citations · 1 hit paper
70 papers, 3.1k citations indexed

About

Bingyang Chu is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Bingyang Chu has authored 70 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Biomedical Engineering, 32 papers in Biomaterials and 20 papers in Molecular Biology. Recurrent topics in Bingyang Chu's work include Nanoparticle-Based Drug Delivery (24 papers), Nanoplatforms for cancer theranostics (24 papers) and Graphene and Nanomaterials Applications (8 papers). Bingyang Chu is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), Nanoplatforms for cancer theranostics (24 papers) and Graphene and Nanomaterials Applications (8 papers). Bingyang Chu collaborates with scholars based in China, Singapore and Hong Kong. Bingyang Chu's co-authors include Zhiyong Qian, Ying Qu, Jinrong Peng, Jinfeng Liao, Danrong Hu, Kun Shi, Feng Luo, Ying Qu, Ying Hao and Kun Shi and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Bingyang Chu

69 papers receiving 3.0k citations

Hit Papers

Activated macrophage memb... 2023 2026 2024 2023 25 50 75

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Bingyang Chu 1.8k 1.4k 867 513 318 70 3.1k
Nitin Joshi 1.7k 1.0× 1.5k 1.1× 1.2k 1.4× 478 0.9× 288 0.9× 40 3.7k
Kun Shi 2.2k 1.2× 1.3k 0.9× 769 0.9× 671 1.3× 255 0.8× 66 3.4k
Yu Fan 1.7k 0.9× 1.6k 1.2× 943 1.1× 565 1.1× 203 0.6× 91 3.7k
Yanbing Zhao 1.6k 0.9× 1.0k 0.8× 532 0.6× 657 1.3× 399 1.3× 72 2.8k
Lesan Yan 1.7k 0.9× 1.6k 1.2× 806 0.9× 678 1.3× 304 1.0× 81 3.6k
Ying Qu 2.0k 1.1× 1.1k 0.8× 566 0.7× 691 1.3× 164 0.5× 45 2.7k
Saji Uthaman 1.4k 0.8× 1.1k 0.8× 805 0.9× 463 0.9× 211 0.7× 76 2.6k
Dongfang Zhou 1.7k 1.0× 1.5k 1.1× 907 1.0× 868 1.7× 163 0.5× 111 3.6k
Dunwan Zhu 1.8k 1.0× 1.4k 1.0× 1.1k 1.2× 536 1.0× 287 0.9× 106 3.4k
James O. Blanchette 1.3k 0.7× 1.6k 1.2× 1.1k 1.3× 434 0.8× 226 0.7× 21 3.0k

Countries citing papers authored by Bingyang Chu

Since Specialization
Citations

This map shows the geographic impact of Bingyang Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingyang Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingyang Chu more than expected).

Fields of papers citing papers by Bingyang Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingyang Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingyang Chu. The network helps show where Bingyang Chu may publish in the future.

Co-authorship network of co-authors of Bingyang Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Bingyang Chu. A scholar is included among the top collaborators of Bingyang Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingyang Chu. Bingyang Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jianan, Ying Qu, Bingyang Chu, et al.. (2025). Research Progress on Biomaterials with Immunomodulatory Effects in Bone Regeneration. Advanced Science. 12(33). e01209–e01209. 4 indexed citations
2.
Zhang, Dongyu, et al.. (2024). Application of biomaterials in cardiac tissue engineering: Current status and prospects. SHILAP Revista de lepidopterología. 3(4). 6 indexed citations
3.
Qu, Ying, Bingyang Chu, Tianzhi Luo, et al.. (2024). Macrophage membrane-biomimetic ROS-responsive platinum nanozyme clusters for acute kidney injury treatment. Biomaterials. 317. 123072–123072. 20 indexed citations
4.
Xu, Yang, Zhongwu Bei, Mei Li, et al.. (2024). Biomaterials for non-invasive trans-tympanic drug delivery: requirements, recent advances and perspectives. Journal of Materials Chemistry B. 12(32). 7787–7813. 4 indexed citations
5.
Yao, Yongchao, Ying Chen, Xun He, et al.. (2024). Bioorthogonal chemistry-based prodrug strategies for enhanced biosafety in tumor treatments: current progress and challenges. Journal of Materials Chemistry B. 12(42). 10818–10834. 1 indexed citations
6.
Feng, Zhanzhan, Shirui Wang, Su Jong Yu, et al.. (2024). Synthesis and identification of a selective FGFR2 degrader with potent antiproliferative effects in gastric cancer. European Journal of Medicinal Chemistry. 277. 116780–116780. 2 indexed citations
7.
Bei, Zhongwu, Lin Ye, Qi Tong, et al.. (2024). Thermostimulated shrinking and adhesive hydrogel dressing for treating chronic diabetic wounds. Cell Reports Physical Science. 5(11). 102289–102289. 15 indexed citations
8.
Xu, Yang, Zhongwu Bei, Mei Li, et al.. (2024). Biomedical application of materials for external auditory canal: History, challenges, and clinical prospects. Bioactive Materials. 39. 317–335. 1 indexed citations
10.
Zeng, Qiang, Bingyang Chu, Zhigang Liu, et al.. (2023). Melphalan-loaded methoxy poly(ethylene glycol)-poly(d,l-lactide) copolymer nanomicelles in the treatment of multiple myeloma. Chinese Chemical Letters. 34(9). 108133–108133. 10 indexed citations
11.
Yang, Xiao, Boguang Yang, Zhinan Yang, et al.. (2023). Bioinspired Tumor‐Targeting and Biomarker‐Activatable Cell‐Material Interfacing System Enhances Osteosarcoma Treatment via Biomineralization. Advanced Science. 10(22). e2302272–e2302272. 22 indexed citations
12.
13.
Hu, Danrong, Meng Pan, Ying Qu, et al.. (2022). Near-infrared light and redox dual-activatable nanosystems for synergistically cascaded cancer phototherapy with reduced skin photosensitization. Biomaterials. 288. 121700–121700. 36 indexed citations
14.
Yang, Yun, Danrong Hu, Yi Lu, et al.. (2021). Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy. Acta Pharmaceutica Sinica B. 12(6). 2710–2730. 46 indexed citations
15.
Hu, Danrong, Lijuan Chen, Ying Qu, et al.. (2018). Oxygen-generating Hybrid Polymeric Nanoparticles with Encapsulated Doxorubicin and Chlorin e6 for Trimodal Imaging-Guided Combined Chemo-Photodynamic Therapy. Theranostics. 8(6). 1558–1574. 191 indexed citations
16.
Xiao, Yao, Kun Shi, Ying Qu, Bingyang Chu, & Zhiyong Qian. (2018). Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor. Molecular Therapy — Methods & Clinical Development. 12. 1–18. 109 indexed citations
17.
Chu, Bingyang, Shuai Shi, Xingyi Li, et al.. (2016). Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy. International Journal of Pharmaceutics. 513(1-2). 118–129. 28 indexed citations
18.
Peng, Jinrong, Tingting Qi, Jinfeng Liao, et al.. (2014). Mesoporous Magnetic Gold “Nanoclusters” as Theranostic Carrier for Chemo-Photothermal Co-therapy of Breast Cancer. Theranostics. 4(7). 678–692. 108 indexed citations
19.
He, Zhiyao, Bingyang Chu, Xiawei Wei, et al.. (2014). Recent development of poly(ethylene glycol)-cholesterol conjugates as drug delivery systems. International Journal of Pharmaceutics. 469(1). 168–178. 45 indexed citations
20.
Wang, Cheng, Chaofeng Long, Xiaoxin Chen, et al.. (2013). Two Novel Nanoscale Preparations of Micelle and Thermosensitive Hydrogel for Docetaxel to Treat Malignant Tumor. Journal of Biomedical Nanotechnology. 9(3). 357–366. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026